These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 9571294)
1. Topographic analysis of EEG photic driving in patients with schizophrenia following clozapine treatment. Jin Y; Potkin SG; Sandman CA; Bunney WE Clin Electroencephalogr; 1998 Apr; 29(2):73-8. PubMed ID: 9571294 [TBL] [Abstract][Full Text] [Related]
2. Clozapine increases EEG photic driving in clinical responders. Jin Y; Potkin SG; Sandman C Schizophr Bull; 1995; 21(2):263-8. PubMed ID: 7631173 [TBL] [Abstract][Full Text] [Related]
3. Computerized EEG profiles of haloperidol, chlorpromazine, clozapine and placebo in treatment resistant schizophrenia. Small JG; Milstein V; Small IF; Miller MJ; Kellams JJ; Corsaro CJ Clin Electroencephalogr; 1987 Jul; 18(3):124-35. PubMed ID: 3652464 [TBL] [Abstract][Full Text] [Related]
4. Spontaneous slow and fast MEG activity in male schizophrenics treated with clozapine. Sperling W; Vieth J; Martus M; Demling J; Barocka A Psychopharmacology (Berl); 1999 Mar; 142(4):375-82. PubMed ID: 10229062 [TBL] [Abstract][Full Text] [Related]
5. Topographic analysis of EEG photic driving in normal and schizophrenic subjects. Jin Y; Sandman CA; Wu JC; Bernat J; Potkin SG Clin Electroencephalogr; 1995 Apr; 26(2):102-7. PubMed ID: 7781188 [TBL] [Abstract][Full Text] [Related]
6. Topographic deficits in alpha-range resting EEG activity and steady state visual evoked responses in schizophrenia. Goldstein MR; Peterson MJ; Sanguinetti JL; Tononi G; Ferrarelli F Schizophr Res; 2015 Oct; 168(1-2):145-52. PubMed ID: 26159669 [TBL] [Abstract][Full Text] [Related]
7. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia. Department of Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Rosenheck R; Cramer J; Xu W; Thomas J; Henderson W; Frisman L; Fye C; Charney D N Engl J Med; 1997 Sep; 337(12):809-15. PubMed ID: 9295240 [TBL] [Abstract][Full Text] [Related]
8. Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics. Potkin SG; Fleming K; Jin Y; Gulasekaram B J Clin Psychopharmacol; 2001 Oct; 21(5):479-83. PubMed ID: 11593072 [TBL] [Abstract][Full Text] [Related]
9. Marked clozapine-induced slowing of EEG background over frontal, central, and parietal scalp areas in schizophrenic patients. Joutsiniemi SL; Gross A; Appelberg B J Clin Neurophysiol; 2001 Jan; 18(1):9-13. PubMed ID: 11290933 [TBL] [Abstract][Full Text] [Related]
10. Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia. Lindenmayer JP; Czobor P; Volavka J; Lieberman JA; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M J Clin Psychiatry; 2004 Apr; 65(4):551-6. PubMed ID: 15119920 [TBL] [Abstract][Full Text] [Related]
11. A machine learning approach using auditory odd-ball responses to investigate the effect of Clozapine therapy. Ravan M; Hasey G; Reilly JP; MacCrimmon D; Khodayari-Rostamabad A Clin Neurophysiol; 2015 Apr; 126(4):721-30. PubMed ID: 25213349 [TBL] [Abstract][Full Text] [Related]
12. Differential effects of long-term treatment with clozapine or haloperidol on GABAA receptor binding and GAD67 expression. Zink M; Schmitt A; May B; Müller B; Demirakca T; Braus DF; Henn FA Schizophr Res; 2004 Feb; 66(2-3):151-7. PubMed ID: 15061247 [TBL] [Abstract][Full Text] [Related]
13. LORETA functional imaging in antipsychotic-naive and olanzapine-, clozapine- and risperidone-treated patients with schizophrenia. Tislerova B; Brunovsky M; Horacek J; Novak T; Kopecek M; Mohr P; Krajca V Neuropsychobiology; 2008; 58(1):1-10. PubMed ID: 18781085 [TBL] [Abstract][Full Text] [Related]
14. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics. Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575 [TBL] [Abstract][Full Text] [Related]
15. Non-linear dynamic analysis of clozapine-induced electroencephalographic changes in schizophrenic patients--a preliminary study. Kang UG; Par KT; Ahn YM; Koo YJ; Yoon SC; Yi SH; Kim YS Prog Neuropsychopharmacol Biol Psychiatry; 2001 Aug; 25(6):1229-39. PubMed ID: 11474842 [TBL] [Abstract][Full Text] [Related]
16. How long to wait for a response to clozapine: a comparison of time course of response to clozapine and conventional antipsychotic medication in refractory schizophrenia. Rosenheck R; Evans D; Herz L; Cramer J; Xu W; Thomas J; Henderson W; Charney D Schizophr Bull; 1999; 25(4):709-19. PubMed ID: 10667741 [TBL] [Abstract][Full Text] [Related]
17. Effects of clozapine on auditory event-related potentials in schizophrenia. Umbricht D; Javitt D; Novak G; Bates J; Pollack S; Lieberman J; Kane J Biol Psychiatry; 1998 Oct; 44(8):716-25. PubMed ID: 9798075 [TBL] [Abstract][Full Text] [Related]
18. Predictors of differential response to clozapine and haloperidol. Veterans Affairs Cooperative Study Group on Clozapine in Refractory Schizophrenia. Rosenheck R; Lawson W; Crayton J; Cramer J; Xu W; Thomas J; Stolar M; Charney D Biol Psychiatry; 1998 Sep; 44(6):475-82. PubMed ID: 9777179 [TBL] [Abstract][Full Text] [Related]
19. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis. Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482 [TBL] [Abstract][Full Text] [Related]
20. Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison. Kane JM; Marder SR; Schooler NR; Wirshing WC; Umbricht D; Baker RW; Wirshing DA; Safferman A; Ganguli R; McMeniman M; Borenstein M Arch Gen Psychiatry; 2001 Oct; 58(10):965-72. PubMed ID: 11576036 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]